Nuvalent to Participate in the UBS 2025 Virtual Oncology Day
CAMBRIDGE, Mass., Sept. 24, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies…
Browsing Tag
Nuvalent
1 post